DNA vaccination with genes encoding Toxoplasma gondii antigens ROP5 and GRA15 induces protective immunity against toxoplasmosis in Kunming mice

References

• Dubey JP. Toxoplasmosis of animals and humans. Second CRC Press, Inc; Boca Raton, NY, USA: 2010. p. 1-313
   Google Scholar
• Robert-Gangneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 2012;25:264-96
   PubMed Web of Science ®Google Scholar
• Tian YM, Huang SY, Miao Q, et al. Genetic characterization of Toxoplasma gondii from cats in Yunnan Province, Southwestern China. Parasit Vectors 2014;7:178
   Google Scholar
• Elmore SA, Jones JL, Conrad PA, et al. Toxoplasma gondii: pidemiology, feline clinical aspects, and prevention. Trends Parasitol 2010;26:190-6
   PubMed Web of Science ®Google Scholar
• Zhou P, Chen ZG, Li HL, et al. Toxoplasma gondii infection in humans in China. Parasit Vectors 2011;4:165
   PubMed Web of Science ®Google Scholar
• Petersen E, Kijlstra A, Stanford M. Epidemiology of ocular toxoplasmosis. Ocul Immunol Inflamm 2012;20:68-75
   PubMed Web of Science ®Google Scholar
• Pereira-Chioccola VL, Vidal JE, Su C. Toxoplasma gondii infection and cerebraltoxoplasmosis in HIV-infected patients. Future Microbiol 2009;4:1363-79
   PubMed Web of Science ®Google Scholar
• Cenci-Goga BT, Rossitto PV, Sechi P, et al. Toxoplasma in animals, food, and humans: an old parasite of new concern. Foodborne Pathog Dis 2011;8:751-62
   PubMed Web of Science ®Google Scholar
• Samra NA, McCrindle CM, Penzhorn BL, et al. Seroprevalence of toxoplasmosis in sheep in South Africa. J S Afr Vet Assoc 2007;78:116-20
   PubMed Web of Science ®Google Scholar
• Innes EA. Vaccination against Toxoplasma gondii: an increasing priority for collaborative research? Expert Rev Vaccines 2010;9:1117-19
   PubMed Web of Science ®Google Scholar
• Zhang NZ, Chen J, Wang M, et al. Vaccines against Toxoplasma gondii: new developments and perspectives. Expert Rev Vaccines 2013;12:1287-99
   PubMed Web of Science ®Google Scholar
• Jongert E, Roberts CW, Gargano N, et al. Vaccines against Toxoplasma gondii: challenges and opportunities. Mem Inst Oswaldo Cruz 2009;104:252-66
   PubMed Web of Science ®Google Scholar
• Chen J, Zhou DH, Li ZY, et al. Toxoplasma gondii: protective immunity induced by rhoptry protein 9 (TgROP9) against acute toxoplasmosis. Exp Parasitol 2014;139:42-8
   PubMed Web of Science ®Google Scholar
• Yuan ZG, Zhang XX, Lin RQ, et al. Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18. Vaccine 2011;29:6614-19
   PubMed Web of Science ®Google Scholar
• Wang PY, Yuan ZG, Petersen E, et al. Protective efficacy of a Toxoplasma gondii rhoptry protein 13 plasmid DNA vaccine in mice. Clin Vaccine Immunol 2012;19:1916-20
   PubMedGoogle Scholar
• Wu XN, Lin J, Lin X, et al. Multicomponent DNA vaccine-encoding Toxoplasma gondii GRA1 and SAG1 primes: anti-Toxoplasma immune response in mice. Parasitol Res 2012;111:2001-9
   PubMed Web of Science ®Google Scholar
• Zhou H, Min J, Zhao Q, et al. Protective immune response against Toxoplasma gondii elicited by a recombinant DNA vaccine with a novel genetic adjuvant. Vaccine 2012;30:1800-6
   PubMed Web of Science ®Google Scholar
• Peng GH, Yuan ZG, Zhou DH, et al. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice. Vaccine 2009;27:6570-4
   PubMed Web of Science ®Google Scholar
• Yuan ZG, Ren D, Zhou DH, et al. Evaluation of protective effect of pVAX-TgMIC13 plasmid against acute and chronic Toxoplasma gondii infection in a murine model. Vaccine 2013;31:3135-9
   PubMed Web of Science ®Google Scholar
• Behnke MS, Khan A, Wootton JC, et al. Virulence differences in Toxoplasma mediated by amplification of a family of polymorphic pseudolinases. Proc Natl Acad Sci USA 2011;108:9631-6
   PubMed Web of Science ®Google Scholar
• Rosowski EE, Lu D, Julien L, et al. Strain-specific activation of the NF-kappaB pathway by GRA15, a novel Toxoplasma gondii dense granule protein. J Exp Med 2011;208:195-212
   PubMed Web of Science ®Google Scholar
• Niedelman W, Gold DA, Rosowski EE, et al. The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response. PLoS Pathog 2012;8:e1002784
   PubMed Web of Science ®Google Scholar
• Mévélec MN, Bout D, Desolme B, et al. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GMCSF plasmid, against acute, chronical and congenital toxoplasmosis in mice. Vaccine 2005;23:4489-99
   PubMed Web of Science ®Google Scholar
• Donnelly JJ, Wahren B, Liu MA. DNA vaccines: progress and challenges. J Immunol 2005;175:633-9
   PubMed Web of Science ®Google Scholar
• Cui YL, He SY, Xue MF, et al. Protective effect of a multiantigenic DNA vaccine against Toxoplasma gondii with co-delivery of IL-12 in mice. Parasite Immunol 2008;30:309-13
   PubMed Web of Science ®Google Scholar
• Chen J, Huang SY, Zhou DH, et al. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice. Vaccine 2013;31:6225-31
   PubMed Web of Science ®Google Scholar
• Chen J, Huang SY, Li ZY, et al. Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice. Vaccine 2013;31:1734-9
   PubMed Web of Science ®Google Scholar
• Yan HK, Yuan ZG, Song HQ, et al. Vaccination with a DNA vaccine coding for perforin-like protein 1 and MIC6 induces significant protective immunity against Toxoplasma gondii. Clin Vaccine Immunol 2012;19:684-9
   PubMedGoogle Scholar
• Li ZY, Chen J, Petersen E, et al. Synergy of mIL-21 and mIL-15 in enhancing DNA vaccine efficacy against acute and chronic Toxoplasma gondii infection in mice. Vaccine 2014;32:3058-65
   PubMed Web of Science ®Google Scholar
• Bounous DI, Campagnoli RP, Brown J. Comparison of MTT colorimetric assay and tritiated thymidine uptake for lymphocyte proliferation assays using chicken splenocytes. Avian Dis 1992;36:1022-7
   PubMed Web of Science ®Google Scholar
• Hoft DF, Eickhoff CS, Giddings OK, et al. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic Trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming. J Immunol 2007;179:6889-900
   PubMed Web of Science ®Google Scholar
• Cherif MS, Shuaibu MN, Kurosaki T, et al. Immunogenicity of novel nanoparticle-coated MSP-1 C-terminus malaria DNA vaccine using different routes of administration. Vaccine 2011;29:9038-50
   PubMed Web of Science ®Google Scholar
• Zhang J, He S, Jiang H, et al. Evaluation of the immune response induced by multiantigenic DNA vaccine encoding SAG1 and ROP2 of Toxoplasma gondii and the adjuvant properties of murine interleukin-12 plasmid in BALB/c mice. Parasitol Res 2007;101:331-8
   PubMed Web of Science ®Google Scholar
• Matowicka-Karna J, Dymicka-Piekarska V, Kemona H. Does Toxoplasma gondii infection affect the levels of IgE and cytokines (IL-5, IL-6, IL-10, IL-12, and TNF-alpha)? Clin Dev Immunol 2009;2009:374696
   Google Scholar
• Gigley JP, Fox BA, Bzik DJ. Cell-mediated immunity to Toxoplasma gondii develops primarily by local Th1 host immune responses in the absence of parasite replication. J Immunol 2009;182:1069-78
   Google Scholar
• Quan JH, Chu JQ, Ismail HA, et al. Induction of protective immune responses by a multiantigenic DNA vaccine encoding GRA7 and ROP1 of Toxoplasma gondii. Clin Vaccine Immunol 2012;19:666-74
   PubMedGoogle Scholar
• Casciotti L, Ely KH, Williams ME, et al. CD8(+)-T-cell immunity against Toxoplasma gondii can be induced but not maintained in mice lacking conventionalCD4(+) T cells. Infect Immun 2002;70:434-43
   PubMedGoogle Scholar
• Tait ED, Jordan KA, Dupont CD, et al. Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+T cells. J Immunol 2010;185:1502-12
   PubMedGoogle Scholar
• Jordan KA, Wilson EH, Tait ED, et al. Kinetics and phenotype of vaccine-induced CD8+ T-cell responses to Toxoplasma gondii. Infect Immun 2009;77:3894-901
   PubMed Web of Science ®Google Scholar
• Zheng B, Lu S, Tong Q, et al. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma gondii is a novel vaccine candidate against toxoplasmosis in mice. Vaccine 2013;31:4578-84
   PubMed Web of Science ®Google Scholar